Risk factors

Company relies heavily on the pending sale of UDENYCA to Intas to pay off $230 million in convertible notes and $47.7 million in royalties.

Customer concentration is high, with three customers accounting for 58% of revenue in 2024. Manufacturing relies heavily on specific, sometimes sole-source, approved vendor steps like plating. Sales cycles are lengthy and variable, often requiring customer product redesigns.

Kinross controls the Manh Choh Project and Peak Gold JV with 70% ownership and management rights. Operations are concentrated in remote Alaska and rely heavily on CEO Rick Van Nieuwenhuyse. The business is subject to gold price volatility and complex environmental regulations.

Demand depends heavily on truck production, economic cycles, and customer concentration among OEMs.

Community West Bancshares faces intense credit risks primarily concentrated in California real estate and commercial loans. The bank is highly exposed to interest rate fluctuations, regulatory capital pressures, and cybersecurity threats.

The company relies heavily on a retail license in the Cayman Islands that is currently under renegotiation with OfReg. Accounts receivable from the Bahamas subsidiary face substantial collection delays, with $28.4 million due and 81% delinquent. A material weakness in internal controls over financial reporting was identified for IT general controls. A single bulk customer, WSC, accounts for 22% of consolidated revenue.

Douglas Elliman is heavily dependent on residential real estate markets, particularly the New York metropolitan area which generated roughly 48% to 52% of revenues from 2022 to 2024. The business faces intense competition for agents, rising mortgage rates from Federal Reserve policies, and declining home inventory levels. Operations are also exposed to regulatory scrutiny and litigation regarding MLS and industry commission practices.

Dermata Therapeutics is a pre-revenue clinical-stage biopharmaceutical company dependent on cash to Q3 2025. The company's lead products are XYNGARI and DMT410. Independent auditors express substantial doubt about the company's ability to continue as a going concern.

Capital intensive operations require continuous funding and reserve replacement amid volatile commodity prices.

Commercial litigation loans drive asset concentration and credit risk. Operations are geographically concentrated in New York City. Deposit concentration among top clients creates funding vulnerability.

Nonperforming assets surged 188.4% to $120.4 million, representing 3.03% of total assets at year-end 2024. Commercial real estate loans heavily concentrate in Louisiana and North Central Texas real estate.

This is an initial filing with no prior year risk factors. The risk profile is dominated by regional real estate lending exposure, interest rate sensitivity, and technology and cyber risks.